Cambridge Healthtech Institute’s 22nd Annual

Cell Culture & Upstream Processing

Achieving Production Excellence at Every Scale

August 12-13, 2026

 

The Cell Culture and Upstream Processing conference delivers in-depth scientific and engineering insight into the technologies shaping today’s biomanufacturing. The program explores advanced media development for complex modalities, intensified and perfusion-based processes, and strategies for scaling biologics beyond traditional mAbs. Attendees will also gain practical guidance on real-time process monitoring, digital twins, predictive modeling, and integration of up- and downstream processing. This meeting equips scientists and engineers with the tools to drive efficiency, ensure product quality, and accelerate next-generation manufacturing innovation.

 

Coverage will include, but is not limited to:

 

  • Media Development & Optimization for Emerging/Complex Modalities
    • Covering bispecifics, multispecifics, conjugates, mRNA, exosomes, and more
    • Perfusion media, richer media for intensified fed-batch
    • Upgrading legacy media platforms
    • Predictive modeling for media optimization
    • Use of transcriptomics and metabolomics to drive media and process design
  • Intensified and Perfusion-Based Upstream Processes
    • Intensified fed-batch, N-1 perfusion, and high-density seed train
    • Continuous and semi-continuous upstream platforms
    • Low vs. high perfusion-rate strategies and media-consumption reduction
    • Intensification and its impact on downstream processes
  • Scale-Up Strategies for Complex Proteins and Non-mAb Modalities
    • Bench-to-production scale-up challenges: pH, DO, glucose, mixing
    • Scale-up vs. scale-up considerations for vectors and vaccines
    • Product quality shifts during scale-up: glycans, potency, aggregation
  • Upstream Automation, Advanced Process Monitoring, and Digital Bioprocessing
    • PAT-enabled monitoring 
    • Real-time control of glycosylation, viability, and productivity
    • Digital twins for upstream optimization
    • Automation in seed trains and perfusion operations
    • Predictive analytics and quality prediction
    • Mechanistic and hybrid modeling for process prediction
  • Upstream to Downstream Integration
    • Harvest clarification strategies
    • Impact of upstream decisions on downstream purification efficiency

 

The deadline for priority consideration is January 23, 2026.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

Opportunities for Participation:

 


For more details on the conference, please contact:

Mimi Langley

Executive Director, Conferences

Cambridge Healthtech Institute

Email: mlangley@healthtech.com

 

For sponsorship information, please contact:

 

Companies A-K

Phillip Zakim-Yacouby

Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-247-1815

Email: philzy@cambridgeinnovationinstitute.com

 

Companies L-Z

Aimee Croke

Senior Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-292-0777

Email: acroke@cambridgeinnovationinstitute.com